# FDA Inspection 1062139 - Vitalant - August 01, 2018

Source: https://www.keypedia.com/records/fda_inspections/vitalant/d526be39-2d8e-463f-88b7-8b7737fcab13
Source feed: FDA_Inspections

> FDA Inspection 1062139 for Vitalant on August 01, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1062139
- Company Name: Vitalant
- Inspection Date: 2018-08-01
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1309894 - 2026-03-25](https://www.keypedia.com/records/fda_inspections/vitalant/805dcd02-6728-4a05-9fd5-4145ea7bc783)
- [FDA Inspection 1309894 - 2026-03-25](https://www.keypedia.com/records/fda_inspections/vitalant/519250f1-391d-4973-b10d-ede3062ed42f)
- [FDA Inspection 1198726 - 2023-02-22](https://www.keypedia.com/records/fda_inspections/vitalant/177d08b1-2c63-46d3-83f9-8a1c53f1c6e3)
- [FDA Inspection 1198726 - 2023-02-22](https://www.keypedia.com/records/fda_inspections/vitalant/44c0bd50-ccfd-46f8-b99f-d63709a95f9e)
- [FDA Inspection 962804 - 2016-03-16](https://www.keypedia.com/records/fda_inspections/vitalant/8f8fc5b8-bb45-44aa-9754-a6a48ac1c44f)

Company: https://www.keypedia.com/companies/vitalant/b8e4b890-4c5b-4e66-bb2c-0ebe739c21c2

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d